Viewing Study NCT00030394


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT00030394
Status: COMPLETED
Last Update Posted: 2013-01-17
First Post: 2002-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module